Human studies have further demonstrated that NKG2DLs are upregulated during the lytic phase of EBV infection, enhancing the susceptibility of infected cells to NKG2D+ NK and T cell–mediated clearance (62, 63). Here, KLRK1 is linked to Epstein-Barr virus infection.